Hainaut M - Search Results

1

Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants.

Van der Linden D, Hainaut M, Goetghebuer T, Haelterman E, Schmitz V, Maes P, Peltier A, Levy J. Van der Linden D, et al. Among authors: hainaut m. Pediatr Infect Dis J. 2007 Apr;26(4):359-61. doi: 10.1097/01.inf.0000258626.34984.eb. Pediatr Infect Dis J. 2007. PMID: 17414406 Clinical Trial.

2

Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1.

Hainaut M, Peltier CA, Gérard M, Marissens D, Zissis G, Levy J. Hainaut M, et al. Eur J Pediatr. 2000 Oct;159(10):778-82. doi: 10.1007/pl00008346. Eur J Pediatr. 2000. PMID: 11039136

3

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor.

Servais J, Hainaut M, Schmitz V, Maes P, Fransen K, Vaira D, Brichard B, Arendt V, Schneider F, Hemmer R, Schmit JC. Servais J, et al. Among authors: hainaut m. Pediatr Infect Dis J. 2002 Mar;21(3):214-20. doi: 10.1097/00006454-200203000-00011. Pediatr Infect Dis J. 2002. PMID: 12005085 Free article.

4

Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.

Mascart F, Verscheure V, Malfroot A, Hainaut M, Piérard D, Temerman S, Peltier A, Debrie AS, Levy J, Del Giudice G, Locht C. Mascart F, et al. Among authors: hainaut m. J Immunol. 2003 Feb 1;170(3):1504-9. doi: 10.4049/jimmunol.170.3.1504. J Immunol. 2003. PMID: 12538714

5

Hainaut M, Ducarme M, Schandene L, Peltier CA, Marissens D, Zissis G, Mascart F, Levy J. Hainaut M, et al. Pediatr Infect Dis J. 2003 Jan;22(1):62-9. doi: 10.1097/00006454-200301000-00016. Pediatr Infect Dis J. 2003. PMID: 12544411 Clinical Trial.

6

Effectiveness of rescue antiretroviral therapy including intravenously administered zidovudine and foscarnet in a child with HIV-1 enteropathy.

Hainaut M, Gérard M, Peltier CA, Souayah H, Mascart F, Zissis G, Levy J. Hainaut M, et al. Eur J Pediatr. 2003 Jul;162(7-8):528-529. doi: 10.1007/s00431-003-1224-9. Epub 2003 May 9. Eur J Pediatr. 2003. PMID: 12739138 No abstract available.

7

Seroreversion in children infected with HIV type 1 who are treated in the first months of life is not a rare event.

Hainaut M, Peltier CA, Goetghebuer T, Van der Linden D, Marissens D, Zissis G, Levy J. Hainaut M, et al. Clin Infect Dis. 2005 Dec 15;41(12):1820-1. doi: 10.1086/498313. Clin Infect Dis. 2005. PMID: 16288411 No abstract available.

8

Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study.

Ene L, Goetghebuer T, Hainaut M, Peltier A, Toppet V, Levy J. Ene L, et al. Among authors: hainaut m. Eur J Pediatr. 2007 Jan;166(1):13-21. doi: 10.1007/s00431-006-0193-1. Epub 2006 Jul 29. Eur J Pediatr. 2007. PMID: 16896646

9

Modulation of the infant immune responses by the first pertussis vaccine administrations.

Mascart F, Hainaut M, Peltier A, Verscheure V, Levy J, Locht C. Mascart F, et al. Among authors: hainaut m. Vaccine. 2007 Jan 4;25(2):391-8. doi: 10.1016/j.vaccine.2006.06.046. Epub 2006 Nov 3. Vaccine. 2007. PMID: 17116347

10

Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis.

Goetghebuer T, Haelterman E, Marvillet I, Barlow P, Hainaut M, Salameh A, Ciardelli R, Gerard M, Levy J. Goetghebuer T, et al. Among authors: hainaut m. Eur J Pediatr. 2009 Jan;168(1):79-85. doi: 10.1007/s00431-008-0717-y. Epub 2008 Apr 5. Eur J Pediatr. 2009. PMID: 18392638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters